Recomendaciones para su abordaje clínico | 10 ENE 20

Incidentalomas suprarrenales

En esta actualización clínica, los autores destacan el abordaje de los tumores suprarrenales incidentales según las directrices internacionales
Autor/a: Hanna F, Issa B, Fryer A y colaboradores BMJ 360(-):1-9, Ene 2018
INDICE:  1. Página 1 | 2. Página 2
Página 2


1 YoungWFJr. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am2000;29:159-85, x. doi:10.1016/S0889-8529(05)70122-510732270

2 TerzoloMStiglianoAChiodiniIItalian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma. Eur J Endocrinol2011;164:851-70. doi:10.1530/EJE-10-114721471169

3 MansmannGLauJBalkERothbergMMiyachiYBornsteinSR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev2004;25:309-40. doi:10.1210/er.2002-003115082524

4 FassnachtMArltWBancosI. Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol2016;175:G1-34. doi:10.1530/EJE-16-046727390021

5 GrumbachMMBillerBMKBraunsteinGD. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med2003;138:424-9. doi:10.7326/0003-4819-138-5-200303040-0001312614096

6 KloosRTGrossMDFrancisIRKorobkinMShapiroB. Incidentally discovered adrenal masses. Endocr Rev1995;16:460-84.8521790

7 BarzonLSoninoNFalloFPaluGBoscaroM. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol2003;149:273-85. doi:10.1530/eje.0.149027314514341

8 BovioSCataldiAReimondoG. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest2006;29:298-302. doi:10.1007/BF0334409916699294

9 MayerSKOlignyLLDealCYazbeckSGagnéNBlanchardH. Childhood adrenocortical tumors: case series and reevaluation of prognosis--a 24-year experience. J Pediatr Surg1997;32:911-5. doi:10.1016/S0022-3468(97)90649-79200099

10 YoungWFJr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med2007;356:601-10. doi:10.1056/NEJMcp06547017287480

11 SuttonMGShepsSGLieJT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc1981;56:354-60.6453259

12 ZeigerMAThompsonGBDuhQYAmerican Association of Clinical EndocrinologistsAmerican Association of Endocrine Surgeons. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract2009;15(Suppl 1):1-20. doi:10.4158/EP.15.S1.119632967

13 KapoorAMorrisTRebelloR. Guidelines for the management of the incidentally discovered adrenal mass. Can Urol Assoc J2011;5:241-7. doi:10.5489/cuaj.1113521801680

14 ManteroFTerzoloMArnaldiGStudy Group on Adrenal Tumors of the Italian Society of Endocrinology. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab2000;85:637-44.10690869

15 NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements2002;19:1-25.14768652

16 BarzonLScaroniCSoninoNFalloFPaolettaABoscaroM. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab1999;84:520-6.10022410

17 ElseTKimACSabolchA. Adrenocortical carcinoma. Endocr Rev2014;35:282-326. doi:10.1210/er.2013-102924423978

18 CaoiliEMKorobkinMFrancisIR. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology2002;222:629-33. doi:10.1148/radiol.222301076611867777

19 HaiderMAGhaiSJhaveriKLockwoodG. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?Radiology2004;231:711-6. doi:10.1148/radiol.231303067615118113

20 BechererAVierhapperHPötziC. FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm2001;16:289-95. doi:10.1089/10849780175313136311602999

21 YunMKimWAlnafisiNLacorteLJangSAlaviA. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med2001;42:1795-9.11752075

22 ShinYRKimKA. Imaging features of various adrenal neoplastic lesions on radiologic and nuclear medicine imaging. AJR Am J Roentgenol2015;205:554-63. doi:10.2214/AJR.15.1446726295641

23 ChangCAPattisonDATothillRW. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity. Cancer Imaging2016;16:22. doi:10.1186/s40644-016-0084-227535829

24 BancosITamhaneSShahM. DIAGNOSIS OF ENDOCRINE DISEASE: The diagnostic performance of adrenal biopsy: a systematic review and meta-analysis. Eur J Endocrinol2016;175:R65-80. doi:10.1530/EJE-16-029727257146

25 ArltWBiehlMTaylorAE. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab2011;96:3775-84. doi:10.1210/jc.2011-156521917861

26 Dennedy MC, Annamalai AK, Prankerd Smith O, et al. Low DHEAS: a sensitive and specific test for detection of subclinical hypercortisolism in adrenal incidentalomas. J Clin Endocrinol Metab 2016;jc.2016-2718.

27 FunderJWCareyRMManteroF. The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab2016;101:1889-916. doi:10.1210/jc.2015-406126934393

28 LendersJWMDuhQ-YEisenhoferGEndocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab2014;99:1915-42. doi:10.1210/jc.2014-149824893135

29 AdachiJHiraiYTeruiK. A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone. Intern Med2003;42:714-8. doi:10.2169/internalmedicine.42.71412924498

30 BaertDNobelsFVan CrombruggeP. Combined Conn’s and Cushing’s syndrome: an unusual presentation of adrenal adenoma. Acta Clin Belg1995;50:310-3. doi:10.1080/17843286.1995.117184688533534



Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí